SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+6.89%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$491M
AUM Growth
+$491M
(+25%)
Cap. Flow
+$65.6M
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
36.88%
Holding
146
New
36
Increased
29
Reduced
18
Closed
21
Top Buys
| 1 |
GSK
GSK
|
$19.4M |
| 2 |
Gilead Sciences
GILD
|
$16.3M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.2M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$8.71M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$7.69M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$24.1M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$7.09M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$5.52M |
| 4 |
CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
|
$5.08M |
| 5 |
Novartis
NVS
|
$4.39M |
Sector Composition
| 1 | Healthcare | 79.26% |
| 2 | Technology | 7.56% |
| 3 | Industrials | 3.16% |
| 4 | Communication Services | 2.73% |
| 5 | Financials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
26
DELISTED
Immunomedics Inc
IMMU
| $4.86M | 0.83% | 550,000 -400,000 | -42% | -$3.53M |
|
27
Union Pacific
UNP
$133B
| $4.62M | 0.78% | 42,400 +13,730 | +48% | +$1.5M |
|
28
Cartesian Therapeutics
RNAC
$261M
| $4.54M | 0.77% | 228,534 | – | – |
|
29
Charter Communications
CHTR
$36.3B
| $4.5M | 0.76% | 13,362 +1,402 | +12% | +$472K |
|
30
Ascendis Pharma
ASND
$11.8B
| $4.49M | 0.76% | 161,617 -93,838 | -37% | -$2.6M |
|
31
Caesarstone
CSTE
$49.1M
| $4.3M | 0.73% | 122,797 +32,823 | +36% | +$1.15M |
|
32
Minerva Neurosciences
NERV
$16.5M
| $4.19M | 0.71% | +473,769 | New | +$4.19M |
|
|
RXDX
33
DELISTED
Ignyta, Inc.
RXDX
| $4.14M | 0.7% | +400,000 | New | +$4.14M |
|
34
Syndax Pharmaceuticals
SNDX
$1.41B
| $4.14M | 0.7% | 296,310 +130,000 | +78% | +$1.82M |
|
35
Aldeyra Therapeutics
ALDX
$351M
| $4.12M | 0.7% | 875,931 +207,431 | +31% | +$975K |
|
|
GBT
36
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.1M | 0.7% | +150,000 | New | +$4.1M |
|
37
Travere Therapeutics
TVTX
$1.56B
| $4.06M | 0.69% | 209,131 | – | – |
|
38
Alphabet (Google) Class A
GOOGL
$2.57T
| $4.04M | 0.69% | 4,346 | – | – |
|
39
Amicus Therapeutics
FOLD
$2.34B
| $4.03M | 0.68% | 400,000 -100,000 | -20% | -$1.01M |
|
40
Alnylam Pharmaceuticals
ALNY
$58.5B
| $3.99M | 0.68% | +50,000 | New | +$3.99M |
|
41
Nomad Foods
NOMD
$2.33B
| $3.78M | 0.64% | +268,072 | New | +$3.78M |
|
|
LJPC
42
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $3.72M | 0.63% | 125,000 +15,000 | +14% | +$447K |
|
|
ICPT
43
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.63M | 0.62% | 30,000 +15,000 | +100% | +$1.82M |
|
|
CBIO
44
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $3.58M | 0.61% | 320,796 -455,000 | -59% | -$5.08M |
|
45
SolarEdge
SEDG
$2.01B
| $3.42M | 0.58% | 171,018 +124,268 | +266% | +$2.49M |
|
|
ADMS
46
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $3.42M | 0.58% | 195,500 | – | – |
|
|
DBVT
47
DBV Technologies
DBVT
$264M
| $3.22M | 0.55% | 90,167 | – | – |
|
48
Corvus Pharmaceuticals
CRVS
$428M
| $3.12M | 0.53% | 257,665 -21,501 | -8% | -$260K |
|
49
CytomX Therapeutics
CTMX
$336M
| $3.1M | 0.53% | 200,000 +50,000 | +33% | +$775K |
|
50
Savara
SVRA
$567M
| $3.1M | 0.53% | +526,315 | New | +$3.1M |
|